(1 - 26 from 41
)
Immunotherapy developer secures $11.4 million for cervical cancer ...
medcitynews.com
Robert Petit, vice president of clinical operations and medical affairs, worked for Bristol-Myers Squibb before he joined Advaxis. He was the U.S. medical strategy lead for its skin cancer drug ipilimumab. He also was director of ...
Dr. Robert Petit Joins Advaxis as VP of Clinical Operations
salesandmarketingnetwork.com
News for Medical Sales & Marketing professionals and Independent Sales Representatives: Dr. Robert Petit Joins Advaxis as V.P. of Clinical Operations.
Advaxis Announces Appointment of Dr. Robert Petit to Chair of Sc ...www.kuam.com/.../advaxis-announces-appointment-of-dr-robert-petit-to-chair-of-scient...
www.kuam.com
Advaxis Announces Appointment of Dr. Robert Petit to Chair of Scientific Advisory Board and Departure as Chief Scientific Officer. Posted: May ...
Advaxis's Chief Scientific Officer, Dr. Robert Petit, Leads Panel...
www.globenewswire.com
Advaxis's Chief Scientific Officer, Dr. Robert Petit, Leads Panel ... cancer immunotherapies, announced that Dr. Robert Petit, its Chief Scientific ...
sorted by relevance / date